🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate experimental medication BMS-986...
Status
Completed
Location
Local Institution - 0059
Start Date
2018-02-12
Trial ID
NCT03400332
Treatments Being Tested
Background: The myelodysplastic syndromes (MDS) are a group of bone marrow...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2022-11-29
Trial ID
NCT05148234
This platform trial will evaluate various immunotherapy combinations given ...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2016-03-28
Trial ID
NCT02451982
Treatments Being Tested
The primary objective of this study is to assess safety and feasibility of ...
Status
Active Not Recruiting
Location
Johns Hopkins University
Start Date
2021-04-24
Trial ID
NCT04848116
The purpose of this research study is to study the effect of giving nivolum...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2020-03-05
Trial ID
NCT04123379
Treatments Being Tested
This study is for patients that are hospitalized for Coronavirus Disease 20...
Status
Terminated
Location
Columbia University Irving Medical Center
Start Date
2020-04-16
Trial ID
NCT04347226
Treatments Being Tested
A phase II clinical trial is utilized to examine whether BMS-986253 (25 sub...
Status
Terminated
Location
NYU Langone Health
Start Date
2019-09-12
Trial ID
NCT04050462
MAGIC-8 is a two-arm, multicenter, phase 1b/2 study to assess the efficacy ...
Status
Active Not Recruiting
Location
Winship Cancer Institute, Emory University
Start Date
2018-10-11
Trial ID
NCT03689699
Treatments Being Tested
In this exploratory study, patients with stage 1-3 adenocarcinoma of the co...
Status
Recruiting
Location
Marieke van de Belt
Start Date
2017-03-29
Trial ID
NCT03026140
Treatments Being Tested
Nivolumab (and other agents affecting the anti-programmed death-1 \[anti-PD...
Status
Active Not Recruiting
Location
University of Chicago Medical Center
Start Date
2021-11-29
Trial ID
NCT04572451
Treatments Being Tested